FAQ – 19 to Zero

Spring COVID-19 Booster – April 2023

“Kraken” COVID Variant XBB.1.5.

Respiratory Syncytial Virus (RSV)

19 to Zero is an independent nonprofit that receives in-kind support, financial funding, and grants from a broad multi-sector network. Funding to support some of 19 to Zero’s activities has been provided by Canadian research-based pharmaceutical grants. The companies have no input into, nor influence over, any aspect of the coalition and its activities. This portal has been funded by a pharmaceutical grant provided by Moderna Canada Inc.

Category: FAQ

Spring COVID-19 Booster – April 2023

The respiratory ‘tripledemic’

“Kraken” COVID Variant XBB.1.5.

Respiratory Syncytial Virus (RSV)

Influenza and Vaccines

COVID-19 Bivalent Vaccines

COVID-19 Vaccines in Children

What To Expect This Fall